Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
Stock Snapshot
With a market cap of 181.48B, Abbott(ABT) trades at $104.20. The stock has a price-to-earnings ratio of 38.29 and currently yields dividends of 2.39%.
On 2026-10-26, Abbott(ABT) stock moved within a range of $102.90 to $105.24. With shares now at $104.20, the stock is trading +1.3% above its intraday low and -1.0% below the session's peak.
Trading activity shows a volume of 7.83M, compared to an average daily volume of 11.11M.
Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $132.03 and a low of $81.97.
Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $132.03 and a low of $81.97.
ABT News
Abbott Laboratories (ABT +0.22%) has had a rough go of it over the past few years. Sales growth hasn't met market expectations, and the company has faced variou...
...
Abbott Laboratories (ABT) has dropped a cluster of market moving headlines in a matter of days, from fresh colorectal cancer test data to a planned Nutrition sp...
Analyst ratings
77%
of 31 ratingsMore ABT News
Healthcare investors often weigh the growth potential of medical technology against the stability of diversified health services. Deciding between Abbott Labora...
Abbott Laboratories has announced plans to separate its global Nutrition division into an independent, publicly traded company with about US$8.5b in annual sale...
Abbott (ABT) announced new Beta-CORRECT data presented at the European Society for Medical Oncology, or ESMO, Congress showing that the whole-genome sequencing,...
RBC Capital lowered the firm’s price target on Abbott (ABT) to $125 from $130 and keeps an Outperform rating on the shares. The firm is taking a more cautious s...
Abbott Laboratories just reported Q3 2026 earnings with adjusted EPS at US$1.42 and comparable sales growth of 7%, yet the stock slipped about 1.9% to US$100.51...
On its third quarter of 2026 earnings call, held on Oct. 21, 2026, Abbott (ABT -1.89%) announced its plan to spin off its nutrition business into an independent...
Abbott Laboratories (NYSE:ABT) announced plans Wednesday to separate its global nutrition business into an independent, publicly traded company by the end of 20...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.